Advertisement
Organisation › Details
Nasdaq Global Market
Start | 2006-07-01 start | |
Group | Nasdaq OMX (Group) | |
Industry | finance | |
City | n. a. | |
Address record changed: 2011-05-15 | ||
Basic data | Employees | n. a. |
Record changed: 2024-10-19 |
Advertisement
More documents for Nasdaq OMX (Group)
- [1] Camp4 Therapeutics Corporation. (10/10/24). "Press Release: Camp4 Announces Pricing of Initial Public Offering". Cambridge, MA....
- [2] Centogene N.V.. (8/7/24). "Press Release: Centogene Receives Delisting Notice From Nasdaq". Cambridge, MA, Rostock & Berlin....
- [3] Affimed N.V.. (3/6/24). "Press Release: Affimed Announces 1-for-10 Reverse Stock Split". Mannheim....
- [4] Centogene N.V.. (2/28/24). "Press Release: Centogene Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing". Cambridge, MA, Rostock & Berlin....
- [5] Abivax S.A.. (10/24/23). "Press Release: Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market". Paris....
- [6] Abivax S.A.. (10/20/23). "Press Release: Abivax Announces the Pricing of Its Initial Public Offering on the Nasdaq Global Market". Paris....
- [7] Abivax S.A.. (9/29/23). "Press Release: Abivax Files Registration Statement for Proposed Initial Public Offering in the United States". Paris....
- [8] RayzeBio, Inc.. (9/14/23). "Press Release: RayzeBio, Inc. Announces Pricing of Upsized $311 Million Initial Public Offering". San Diego, CA....
- [9] Abivax S.A.. (8/21/23). "Press Release: Abivax Secures Up to EUR 150M from Two Structured Debt Financing Transactions". Paris....
- [10] BiondVax Pharmaceuticals Ltd.. (8/1/23). "Press Release: Nasdaq Grants BiondVax Extension to Regain Compliance with Listing Rules". Jerusalem....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top